Toll-like receptor alterations in myelodysplastic syndrome
暂无分享,去创建一个
D. Neuberg | B. Ebert | R. Bejar | O. Abdel-Wahab | R. Levine | H. Kantarjian | G. Garcia-Manero | C. Bueso-Ramos | R. Chen | Hui Wang | Xia Wang | Sa A. Wang | M. Kleppe | Hui Yang | Rui Chen | S. Pierce | Hong Zheng | S. Pierce | H. Wang | M. Nguyen | Yue Wei | R. Levine | I. Ganan-Gomez | Y. Wei | H. Yang | S. Dimicoli | X. Wang | B. Ebert | Y. Jia | H. Zheng | S. A. Wang | R. Chen | C. Bueso‐Ramos | Yu Jia | R. Levine
[1] D. Neuberg,et al. Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells , 2013, Leukemia.
[2] Aristóbolo Mendes Silva,et al. Toll-Like Receptor 6 Plays an Important Role in Host Innate Resistance to Brucella abortus Infection in Mice , 2013, Infection and Immunity.
[3] A. Parker,et al. STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation. , 2012, Cancer cell.
[4] J. Tyner,et al. p38 MAPK inhibition suppresses the TLR-hypersensitive phenotype in FANCC- and FANCA-deficient mononuclear phagocytes. , 2012, Blood.
[5] L. Nie,et al. Chronic Exposure to a TLR Ligand Injures Hematopoietic Stem Cells , 2011, The Journal of Immunology.
[6] K. Tracey,et al. HMGB1 is a therapeutic target for sterile inflammation and infection. , 2011, Annual review of immunology.
[7] M. Goodell,et al. Inflammatory signals regulate hematopoietic stem cells. , 2011, Trends in immunology.
[8] K. Coombes,et al. Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia. , 2010, Blood.
[9] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[10] H. Prince,et al. Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients , 2010, Leukemia.
[11] Adeline R. Whitney,et al. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. , 2010, Blood.
[12] S. Paik,et al. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. , 2009, Immunity.
[13] Jane Yates,et al. TLR8-dependent TNF-(alpha) overexpression in Fanconi anemia group C cells. , 2009, Blood.
[14] L. Genestier,et al. The TLR1/2 agonist PAM3CSK4 instructs commitment of human hematopoietic stem cells to a myeloid cell fate , 2009, Leukemia.
[15] J. Ashwell,et al. Lys63-Linked Polyubiquitination of IRAK-1 Is Required for Interleukin-1 Receptor- and Toll-Like Receptor-Mediated NF-κB Activation , 2008, Molecular and Cellular Biology.
[16] M. Sioud,et al. TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1‐type response , 2007, European journal of immunology.
[17] G. Natoli,et al. The Histone H3 Lysine-27 Demethylase Jmjd3 Links Inflammation to Inhibition of Polycomb-Mediated Gene Silencing , 2007, Cell.
[18] P. Ahmad-Nejad,et al. Characterization and investigation of single nucleotide polymorphisms and a novel TLR2 mutation in the human TLR2 gene. , 2007, Human molecular genetics.
[19] E. Andreakos,et al. Toll-like Receptor-4 Is Up-Regulated in Hematopoietic Progenitor Cells and Contributes to Increased Apoptosis in Myelodysplastic Syndromes , 2007, Clinical Cancer Research.
[20] S. Akira,et al. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. , 2006, Immunity.
[21] S. Akira,et al. Pathogen Recognition and Innate Immunity , 2006, Cell.
[22] S. Nimer,et al. Severe and selective deficiency of interferon‐γ‐producing invariant natural killer T cells in patients with myelodysplastic syndromes , 2003, British journal of haematology.
[23] Sophie Janssens,et al. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. , 2003, Molecular cell.
[24] S. Akira,et al. Cutting Edge: Role of Toll-Like Receptor 1 in Mediating Immune Response to Microbial Lipoproteins1 , 2002, The Journal of Immunology.
[25] D. Starczynowski,et al. Deregulation of microRNAs in myelodysplastic syndrome , 2012, Leukemia.
[26] Ryan D. Morin,et al. Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype , 2010, Nature Medicine.
[27] A. Tefferi,et al. Myelodysplastic syndromes. , 2009, The New England journal of medicine.
[28] R. Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[29] Claude-Alain H. Roten,et al. Fast and accurate short read alignment with Burrows–Wheeler transform , 2009, Bioinform..
[30] S. Akira,et al. TLR signaling. , 2006, Cell death and differentiation.